Fagiolini, A. (2011) “Pharmacoeconomic comparison of ziprasidone with other atypical oral antipsychotic agents in schizophrenia”, Farmeconomia. Health economics and therapeutic pathways, 12(1), pp. 29–40. doi: 10.7175/fe.v12i1.96.